- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | QTREX Quantum Ltd.: One of Israel's 3 Largest Defense Companies Begins Immediate Deployment of QTREX Quantum's AME Technology | 2 | GlobeNewswire (USA) | ||
| Mo | QTREX Quantum Ltd.: QTREX to Unveil Ultra-High-Density Interconnect Architecture Supporting 17,280 Coaxial Lines per Cryogenic Stage at IEEE Quantum Week 2026 | 4 | GlobeNewswire (USA) | ||
| 28.08. | QTREX Quantum Ltd. - 6-K, Report of foreign issuer | 7 | SEC Filings | ||
| QTREX QUANTUM Aktie jetzt für 0€ handeln | |||||
| 20.08. | QTREX Quantum nimmt 10 Millionen US-Dollar über Direktplatzierung ein | 6 | Investing.com Deutsch | ||
| 20.08. | QTREX Quantum Ltd.: QTREX Announces Pricing of a $10 Million Registered Direct Offering of Ordinary Shares | 1 | GlobeNewswire (USA) | ||
| 19.08. | QTREX develops laser-printed carbon conductors for quantum chips | 4 | Investing.com | ||
| 19.08. | QTREX Quantum Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 19.08. | QTREX Quantum Ltd.: QTREX's Patent-Pending Technology Achieves First Direct Conversion of 3D-Printed Insulation into Graphene-Like Carbon to Protect Quantum Processors | 1 | GlobeNewswire (USA) | ||
| 03.08. | QTREX Quantum Ltd. - 6-K, Report of foreign issuer | 4 | SEC Filings | ||
| 31.07. | QTREX Quantum Ltd.: QTREX Proprietary Quantum Interconnect Platform Exceeds Performance Requirements Established by Strategic Partners | 3 | GlobeNewswire (USA) | ||
| 27.07. | QTREX Quantum Ltd.: QTREX Launches Quantum Interconnect Research Program with Commercialization Rights to Project-Generated IP | 7 | GlobeNewswire (USA) | ||
| 22.07. | QTREX clarifies F-1 filing relates to existing warrants only | 2 | Investing.com | ||
| 22.07. | QTREX stellt klar: F-1-Einreichung bezieht sich nur auf bestehende Optionsscheine | 5 | Investing.com Deutsch | ||
| 22.07. | QTREX Quantum Ltd.: QTREX Announces Clarification to Registration Statement on Form F-1 | 231 | GlobeNewswire (Europe) | Ness Ziona, Israel, July 22, 2026 (GLOBE NEWSWIRE) -- QTREX Quantum Ltd. (Nasdaq: QTEX) ("QTREX" or the "Company") a company focused on advancing Additively Manufactured Electronics ("AME") for quantum... ► Artikel lesen | |
| 21.07. | QTREX Quantum Ltd. - F-1, Registration statement for certain foreign private issuers | 2 | SEC Filings | ||
| 21.07. | QTREX Quantum Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 21.07. | QTREX Quantum Ltd. - S-8, Securities to be offered to employees in employee benefit plans | 2 | SEC Filings | ||
| 17.07. | QTREX Quantum Ltd.: QTREX Appoints Dr. Shlomit Chappel-Ram, Veteran AME R&D Executive, as Independent Director | 1 | GlobeNewswire (USA) | ||
| 15.07. | NSE - QTREX Quantum Ltd. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | 2 | SEC Filings | ||
| 14.07. | QTREX secures commercial order for shielded RF monolithic components | 5 | Seeking Alpha |
1 2 3 4 5 Weiter >>
88 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 5,396 | -0,15 % | Teladoc Health, Inc.: Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08 | ||
| SERNOVA BIOTHERAPEUTICS | 0,065 | -7,39 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Receives FDA Orphan Drug Designation for Autologous Islet Transplantation for Prevention of Diabetes Due to Total Pancreatectomy | TORONTO and BOSTON, June 17, 2026 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics Inc. ("Sernova" or the "Company") (TSX: SVA) (OTC: SEOVF) (FSE/XETRA: PSHO), a leading regenerative medicine company focused... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 2,160 | 0,00 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update | SEATTLE, Aug. 7, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel... ► Artikel lesen | |
| TANDEM DIABETES | 17,500 | +1,74 % | Aus TNDM Trucking wird Girteka Dedicated | ||
| CO-DIAGNOSTICS | 1,160 | 0,00 % | Co-Diagnostics, Inc. - 8-K, Current Report | ||
| QUIDELORTHO | 11,790 | -1,95 % | QuidelOrtho Corporation: QuidelOrtho Reports Second Quarter 2026 Financial Results | ? Total revenue grew 3% reported and 2% constant currency, primarily driven by Labs and Point of Care growth ?
? Excluding China, total revenue grew 6% both as... ► Artikel lesen | |
| VERU | 2,640 | 0,00 % | Veru Inc.: Veru Reports Fiscal 2026 Third Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress | -- Phase 2b PLATEAU clinical trial of enobosarm and semaglutide combination for high quality weight loss is fully enrolled with 239 patients - -- Phase 2b PLATEAU clinical trial interim analysis and... ► Artikel lesen | |
| LIFEWARD | 7,000 | +0,14 % | Lifeward Ltd.: Lifeward Appoints Josh Hexter Interim Chief Executive Officer and Rami Aviram Chief Financial Officer | HUDSON, Mass. and YOKNEAM ILLIT, Israel, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) ("Lifeward" or the "Company"), a diversified biomedical innovation company with a portfolio... ► Artikel lesen | |
| CLOVER HEALTH INVESTMENTS | 3,650 | -0,54 % | Clover Health (CLOV) Turns Profitable As Medicare Membership Explodes | ||
| SENSEONICS | 8,200 | -1,20 % | Senseonics sees activist investor take a major stake | ||
| NANO-X IMAGING | 0,820 | -1,18 % | NANO-X IMAGING LTD: Nanox Signs Distribution Agreement with Associated X-Ray Imaging to Expand Nanox.ARC Adoption Across New England | Expands Nanox's growing U.S. distribution network with a leading New England-based medical imaging provider
PETACH TIKVA, Israel - September 4 2026 - Nano-X Imaging Ltd. ("Nanox", or the "Company"... ► Artikel lesen | |
| FULGENT GENETICS | 17,300 | +1,76 % | Fulgent expects $330M-$340M 2026 revenue as billing transition lowers collection rates | ||
| PERSPECTIVE THERAPEUTICS | 2,658 | -1,85 % | Perspective Therapeutics, Inc.: Perspective Therapeutics Provides Recent Business Highlights and Reports 2Q 2026 Results | Advancing VMT-a-NET toward a Phase 3 study in neuroendocrine tumors, subject to regulatory alignment: regulatory engagement ongoing; clinical site activation targeted around year-end 2026 subject... ► Artikel lesen | |
| VIRIDIAN THERAPEUTICS | 19,800 | 0,00 % | Aktien New York Ausblick: Nasdaq erholt - Comcast-Aufspaltung beflügelt Branche | NEW YORK (dpa-AFX) - Die Anleger dürften den jüngsten Kursrückschlag an der New Yorker Tech-Börse Nasdaq direkt zum Wiedereinstieg nutzen. Im Fokus stehen am Montag die jüngste Entspannung im davor... ► Artikel lesen | |
| NUWELLIS, INC | 0,773 | -1,08 % | Nuwellis, Inc.: Nuwellis Strengthens Product Development Organization with Appointment of Dale Brady as Principal R&D Engineer | MINNEAPOLIS, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today announced... ► Artikel lesen |
Das Unternehmen QTREX QUANTUM LTD kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell -0,42 % bei einem Aktienkurs von 0,830 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu QTREX QUANTUM LTD finden Sie auf Wallstreet Online.